| 2024-05 |
Poor Mobilization-Associated Factors in Autologous Hematopoietic Stem Cell Harvest |
Cancers
|
| 2024-03 |
Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry |
Journal of Korean Medical Science
|
| 2024-02 |
Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study |
Frontiers in Oncology
|
| 2024-01 |
A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea |
Journal of Korean Medical Science
|
| 2024-01 |
Clearing soluble MIC reverses the impaired function of natural killer cells from patients with multiple myeloma |
Journal for ImmunoTherapy of Cancer
|
| 2023-12 |
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial |
LANCET HAEMATOLOGY
|
| 2023-12 |
Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region |
Asia-Pacific Journal of Clinical Oncology
|
| 2023-12 |
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial |
The Lancet Haematology
|
| 2023-11 |
Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation |
Investigative ophthalmology & visual science
|
| 2023-10 |
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) |
FRONTIERS IN ONCOLOGY
|
| 2023-10 |
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis |
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
|
| 2023-10 |
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea |
Journal of Korean Medical Science
|
| 2023-10 |
Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study |
Cancer Research and Treatment
|
| 2023-08 |
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone |
The American journal of gastroenterology
|
| 2023-08 |
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial |
EUROPEAN JOURNAL OF HAEMATOLOGY
|
| 2023-07 |
Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea |
Haemophilia
|
| 2023-04 |
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study |
Cancer Research and Treatment
|
| 2023-04 |
Mitigating Drug–Target–Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors |
Clinical Pharmacology and Therapeutics
|
| 2023-04 |
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA |
Annals of Hematology
|
| 2023-03 |
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH) |
Blood Research
|
| 2023-03 |
The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report |
Korean Journal of Transplantation
|
| 2023-03 |
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results |
Haematologica
|
| 2023-02 |
DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation |
Cancers
|
| 2023-01 |
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts |
Cancer Research and Treatment
|
| 2022-10 |
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease |
JOURNAL OF HEMATOLOGY & ONCOLOGY
|
| 2022-09 |
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the <scp>CANDOR</scp> study |
British Journal of Haematology
|
| 2022-09 |
Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study |
Blood Research
|
| 2022-09 |
국내 Human Research Protection Program 도입 과정과 발전 방향에 대한 고찰 |
Journal of KAIRB
|
| 2022-08 |
Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study) |
Frontiers in Oncology
|
| 2022-08 |
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis |
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
|
| 2022-08 |
Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma |
BRITISH JOURNAL OF HAEMATOLOGY
|
| 2022-05 |
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma |
SCIENTIFIC REPORTS
|
| 2022-04 |
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment |
THERAPEUTIC ADVANCES IN HEMATOLOGY
|
| 2022-04 |
Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study |
CANCER RESEARCH AND TREATMENT
|
| 2022-03 |
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations |
Blood Research
|
| 2022-02 |
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features |
Current Problems in Cancer
|
| 2022-02 |
Limite d b enefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea |
CURRENT PROBLEMS IN CANCER
|
| 2022-02 |
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study |
Clinical Lymphoma Myeloma & Leukemia
|
| 2022-01 |
Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients |
Journal of Molecular Diagnostics
|
| 2021-12 |
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea |
Blood Research
|
| 2021-10 |
다발골수종 및 관련 형질세포 질환의 조기 진단을 위한 선별 검사 |
대한내과학회지 = The Korean Journal of Medicine
|
| 2021-09 |
Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study |
BLOOD ADVANCES
|
| 2021-09 |
국내 임상시험 및 대상자 보호프로그램 도입 현황과 안전관리체계에 대한 설문조사 연구 |
Journal of KAIRB
|
| 2021-09 |
Risk factors for neutropenic fever in non-Hodgkin’s lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-06 |
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea |
HAEMOPHILIA
|
| 2021-05 |
Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma |
CLINICAL CANCER RESEARCH
|
| 2021-04 |
Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients |
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
|
| 2021-04 |
Combination treatment of copanlisib and gemcitabine in relapsed refractory PTCL (COSMOS): an open-label phase I/II trial |
ANNALS OF ONCOLOGY
|
| 2021-04 |
Updated recommendations for the treatment of venous thromboembolism |
Blood Research
|
| 2021-04 |
Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients |
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
|
| 2021-04 |
Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells |
Experimental Hematology and Oncology
|
| 2021-03 |
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-02 |
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study |
JOURNAL OF HEMATOLOGY & ONCOLOGY
|
| 2021-02 |
Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma |
SUPPORTIVE CARE IN CANCER
|
| 2021-01 |
Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2020-12 |
Human herpesvirus 8-negative effusion-based lymphoma with indolent clinical behavior in an elderly patient: A case report and literature review |
ONCOLOGY LETTERS
|
| 2020-11 |
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX |
BLOOD CANCER JOURNAL
|
| 2020-11 |
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis |
LEUKEMIA & LYMPHOMA
|
| 2020-10 |
Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome |
THROMBOSIS RESEARCH
|
| 2020-10 |
Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database |
CANCER RESEARCH AND TREATMENT
|
| 2020-10 |
Immunosuppressive role of CD11b+CD33+HLA-DR− myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia |
CANCER MEDICINE
|
| 2020-09 |
Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma |
ANNALS OF HEMATOLOGY
|
| 2020-08 |
First-line treatment for primary breast diffuse large B-cell lymphoma using immunochemotherapy and central nervous system prophylaxis: A multicenter phase 2 trial |
Cancers
|
| 2020-08 |
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial |
CANCER RESEARCH AND TREATMENT
|
| 2020-08 |
Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners |
PATIENT EDUCATION AND COUNSELING
|
| 2020-07 |
Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL) |
BONE MARROW TRANSPLANTATION
|
| 2020-07 |
Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era |
SCIENTIFIC REPORTS
|
| 2020-07 |
Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study |
INTERNATIONAL JOURNAL OF HEMATOLOGY
|
| 2020-05 |
Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease |
ANNALS OF HEMATOLOGY
|
| 2020-05 |
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
|
| 2020-04 |
PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells |
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
|
| 2020-03 |
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria |
Blood
|
| 2019-12 |
국소적 대상포진이 발생한 면역저하환자로부터 유발된 수두의 발생 |
병원감염관리
|
| 2019-11 |
Induction of apoptosis and differentiation by Na/H exchanger 1 modulation in acute myeloid leukemia cells |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
|
| 2019-10 |
Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis |
ANNALS OF HEMATOLOGY
|
| 2019-10 |
Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia |
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
|
| 2019-07 |
Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosaassociated lymphoid tissue lymphoma:implications for radiotherapy optimization |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
|
| 2019-07 |
A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study |
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
|
| 2019-05 |
Acquired Hemophilia A |
Clinical & experimental thrombosis and hemostasis
|
| 2018-10 |
HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma |
CANCER RESEARCH AND TREATMENT
|
| 2018-05 |
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) |
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
|
| 2017-12 |
Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma |
HEMATOLOGICAL ONCOLOGY
|
| 2017-11 |
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma |
ONCOTARGET
|
| 2017-11 |
Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma |
ONCOTARGET
|
| 2017-11 |
Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores |
ANNALS OF HEMATOLOGY
|
| 2017-10 |
Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma |
ONCOTARGET
|
| 2017-10 |
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160) |
ONCOTARGET
|
| 2017-10 |
Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study |
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
|
| 2017-09 |
Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort |
Blood Research
|